Inventor · disambiguated record
Ian Linney
Also filed as: LINNEY IAN · LINNEY IAN D · LINNEY IAN DUNCAN
36 granted patents·7 pending applications·109 citations·filing 1997–2024
96Inventor score
Top patents by PatentIndex Score
43 records- 0197US11034694B2Substituted isoindolin-1-ones and 2,3-dihydro-1H-pyrrolo[3,4-c]pyridin-1-ones as HPK1 antagonistsNIMBUS SATURN INC·Filed 2020·Granted Jun 15, 2021·12 cites·22 claims
- 0296US11078201B2Substituted isoindolin-1-ones and 2,3-dihydro-1H-pyrrol[3,4-c]pyridin-1-ones as HPK1 antagonistsNIMBUS SATURN INC·Filed 2020·Granted Aug 3, 2021·7 cites·22 claims
- 0396US11028085B2Substituted isoindolin-1-ones and 2,3-dihydro-1h-pyrrolo[3,4-c]pyridin-1-ones as hpk1 antagonistsNIMBUS SATURN INC·Filed 2020·Granted Jun 8, 2021·6 cites·22 claims
- 0496US11021481B2Substituted isoindolin-1-ones and 2,3-dihydro-1h-pyrrolo[3,4-c]pyridin-1-ones as HPK1 antagonistsNIMBUS SATURN INC·Filed 2020·Granted Jun 1, 2021·7 cites·22 claims
- 0595US11548890B1HPK1 antagonists and uses thereofNIMBUS SATURN INC·Filed 2021·Granted Jan 10, 2023·3 cites·30 claims
- 0693US11820751B2Urolithin derivatives and methods of use thereofVANDRIA SA·Filed 2022·Granted Nov 21, 2023·3 cites·6 claims
- 0786US11926625B2HPK1 antagonists and uses thereofNIMBUS SATURN INC·Filed 2022·Granted Mar 12, 2024·1 cites·17 claims
- 0884US12473269B2Urolithin derivatives and methods of use thereofVANDRIA SA·Filed 2023·Granted Nov 18, 2025·0 cites·12 claims
- 0983US12358884B2Urolithin derivatives and methods of use thereofVANDRIA SA·Filed 2023·Granted Jul 15, 2025·0 cites·20 claims
- 1083US2024025898A1Hpk1 antagonists and uses thereofNIMBUS SATURN INC·Filed 2023·Application pending·0 cites
- 1182US12351567B2Urolithin derivatives and methods of use thereofVANDRIA SA·Filed 2023·Granted Jul 8, 2025·0 cites·19 claims
- 1281US8853193B2Thienopyrimidines containing a substituted alkyl group for pharmaceutical compositionsHECKEL ARMIN·Filed 2011·Granted Oct 7, 2014·7 cites·11 claims
- 1379US8980913B2Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activityCHIESI FARMA SPA·Filed 2013·Granted Mar 17, 2015·4 cites·10 claims
- 1478US8754079B2Cycloalkyl containing thienopyrimidines for pharmaceutical compositionsLEHMANN-LINTZ THORSTEN·Filed 2011·Granted Jun 17, 2014·6 cites·13 claims
- 1577US10004728B2Compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activityCHIESI FARM SPA·Filed 2017·Granted Jun 26, 2018·2 cites·12 claims
- 1676US9579314B2Compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activityCHIESI FARM SPA·Filed 2016·Granted Feb 28, 2017·2 cites·14 claims
- 1775US12466841B2Substituted pyrrolo[3,4-c]pyridines as HPK1 antagonistsNIMBUS SATURN INC·Filed 2023·Granted Nov 11, 2025·0 cites·24 claims
- 1875US9662323B2Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activityCHIESI FARM SPA·Filed 2016·Granted May 30, 2017·2 cites·16 claims
- 1975US8486953B2Thienopyrimidines for pharmaceutical compositionsAUSTEN MATTHIAS·Filed 2009·Granted Jul 16, 2013·3 cites·17 claims
- 2075US7105558B2Gastrin and cholecystokinin receptor lignads (iv)BLACK JAMES FOUNDATION·Filed 2001·Granted Sep 12, 2006·7 cites·31 claims
- 2174US8877774B2Compounds having muscarinic receptor antagonist and beta2 Adrenergic receptor agonist activityRANCATI FABIO·Filed 2012·Granted Nov 4, 2014·4 cites·21 claims
- 2273US9371318B2Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activityCHIESI FARMA SPA·Filed 2015·Granted Jun 21, 2016·1 cites·19 claims
- 2373US9012644B2Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activityRANCATI FABIO·Filed 2012·Granted Apr 21, 2015·3 cites·19 claims
- 2472US12215105B2HPK1 antagonists and uses thereofNIMBUS SATURN INC·Filed 2020·Granted Feb 4, 2025·0 cites·18 claims
- 2572US2024199603A1Hpk1 antagonists and uses thereofNIMBUS SATURN INC·Filed 2024·Application pending·0 cites
- 2669US8987299B2Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activityCHIESI FARMA SPA·Filed 2013·Granted Mar 24, 2015·4 cites·10 claims
- 2766US12071442B2Substituted pyrrolo[3,4-c]pyridines as HPK1 antagonistsNIMBUS SATURN INC·Filed 2022·Granted Aug 27, 2024·0 cites·19 claims
- 2860US2025011331A1Hpk1 antagonists and uses thereofNIMBUS SATURN INC·Filed 2022·Application pending·0 cites
- 2958US2025136577A1Heterocyclic derivatives as malt1 inhibitorsC4X DISCOVERY LTD·Filed 2023·Application pending·0 cites
- 3055US12252488B2HPK1 antagonists and uses thereofNIMBUS SATURN INC·Filed 2022·Granted Mar 18, 2025·0 cites·22 claims
- 3152US6479531B1Gastrin and cholecystokinin receptor ligandsBLACK JAMES FOUNDATION·Filed 1999·Granted Nov 12, 2002·14 cites·23 claims
- 3250US10117860B2Aminoester derivativesCHIESI FARM SPA·Filed 2017·Granted Nov 6, 2018·0 cites·17 claims
- 3346US6878736B1Histamine H3 receptor ligandsBLACK JAMES FOUNDATION·Filed 1999·Granted Apr 12, 2005·7 cites·11 claims
- 3445US2007082892A1Benzotriazepine derivatives and their use as gastrin and cholecystokinin receptor ligandsBLACK JAMES FOUNDATION·Filed 2004·Application pending·0 cites
- 3543US9763924B2Aminoester derivativesCHIESI FARM SPA·Filed 2015·Granted Sep 19, 2017·0 cites·16 claims
- 3642US9453013B2Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activityCHIESI FARM SPA·Filed 2015·Granted Sep 27, 2016·0 cites·16 claims
- 3741US6057311ABenzodiazonine derivatives binding to cholecystokinin or gastrin receptorsBLACK JAMES FOUNDATION·Filed 1997·Granted May 2, 2000·2 cites·34 claims
- 3840US10196386B2Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activityCHIESI FARM SPA·Filed 2017·Granted Feb 5, 2019·0 cites·20 claims
- 3940US2006003993A1Benzotriazepnes as gastrin and cholecystokinin receptor ligandsBLACK JAMES FOUNDATION·Filed 2002·Application pending·0 cites
- 4039US6355665B11H-4(5)-substituted imidazole derivatives, their preparation and their use as histamine H3 receptor ligandsBLACK JAMES FOUNDATION·Filed 1998·Granted Mar 12, 2002·2 cites·4 claims
- 4138US9932338B2Compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activityCHIESI FARM SPA·Filed 2016·Granted Apr 3, 2018·0 cites·17 claims
- 4236US2013065914A1Halogen or cyano substituted thieno [2,3-d]pyrimidines having mnk1/mnk2 inhibiting activity for pharmaceutical compositionsHECKEL ARMIN·Filed 2011·Application pending·0 cites
- 4334US8648068B2Heterocycloalkyl-containing thienopyrimidines for pharmaceutical compositionsLEHMANN-LINTZ THORSTEN·Filed 2011·Granted Feb 11, 2014·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Ian Linney files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →